Clinical Trials Directory

Trials / Unknown

UnknownNCT02105194

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Cerebral Decompression Illness

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Paul G. Harch, M.D. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Chart review of patients who received hyperbaric oxygen therapy for cerebral decompression illness who also underwent SPECT brain blood flow imaging to see if SPECT brain imaging tracks and is consistent with the clinical condition of the patients.

Detailed description

SPECT brain imaging has been shown to be the most sensitive imaging modality for cerebral decompression illness. This study is a retrospective review of the PI's experience using SPECT brain imaging in the diagnosis and treatment of all phases of cerebral decompression illness over the past two decades. The purpose of the study is to see if the functional imaging is consistent with the clinical condition and cognitive testing. Chart review of symptoms, and physical exam findings will be compared before and after treatment to SPECT brain imaging radiological readings to assess concordance.

Conditions

Interventions

TypeNameDescription
DRUGHyperbaric oxygen therapytotal body exposure to greater than atmospheric pressure oxygen

Timeline

Start date
2007-01-01
Primary completion
2017-12-01
Completion
2018-12-01
First posted
2014-04-07
Last updated
2017-04-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02105194. Inclusion in this directory is not an endorsement.